SynthesisActa parasitologica2021
History of Human Schistosomiasis (bilharziasis) in China: From Discovery to Elimination.
Synthesis in Acta parasitologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.
- Changing seroprevalence of schistosomiasis japonica in China from 1982 to 2020: A systematic review and spatial analysis.PLoS neglected tropical diseases · 2024Pooled it
- Prevalence of depressive symptoms in patients with advanced schistosomiasis in China: A systematic review and meta-analysis.PLoS neglected tropical diseases · 2024Pooled it
- Controlling mountain-type zoonotic visceral leishmaniasis in China: Current progress and challenges through a One Health lens.One health (Amsterdam, Netherlands) · 2026Article
- Development of a Novel Quantitative PCR Assay for DetectingPathogens (Basel, Switzerland) · 2026Article
- Ecological environmental management program promotes Schistosomiasis control in Erhai Lake of China: an analysis based on SWOT-ANP-ADAM approach.Infectious diseases of poverty · 2026Article
- Schistosomiasis japonicum burden in adult villagers of Qingshan Island, China: a cross-sectional study on prevalence, intensity, knowledge and risk factors.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025Article
- Epidemiological Characteristics and Trends of Zoonotic Diseases in China from 2015 to 2022.Tropical medicine and infectious disease · 2025Article
- Schistosomiasis and water resources development in Africa: A scoping review and multi-case evaluation of associated snail control.PLoS neglected tropical diseases · 2025Article
- Understanding the Feasibility to Implement Schistosomiasis Elimination Project Under China-Zimbabwe Cooperation: A Pilot Study Protocol.Journal of epidemiology and global health · 2025Article
- Seropositive Rate and Associated Factors of Schistosomiasis in Hunan Province, China: A Three-Year Cross-Sectional Survey.Acta parasitologica · 2025Article
- Risk Prediction of Emerging Sites Infested with Schistosome-Transmitting Oncomelania hupensis in Shanghai, China.The American journal of tropical medicine and hygiene · 2025Article
- Population genetic diversity of Schistosoma japonicum arises from the host switching in the life cycle.PLoS neglected tropical diseases · 2025Article
- The genetic diversity of Oncomelania hupensis robertsoni, intermediate hosts of Schistosoma japonicum in hilly regions of China, using microsatellite markers.Parasites & vectors · 2024Article
- Diterpenoids with Schistosomula-Killing and Anti-Fibrosis Activities In Vitro from the Leaves ofMolecules (Basel, Switzerland) · 2024Article
- The cultural policies of schistosomiasis control in China: a historical analysis.Parasitology research · 2023Review
- Article
- Trend of Human Schistosomiasis Japonica Prevalence in China from 1990 to 2019.Tropical medicine and infectious disease · 2023Article
- Life expectancy and healthy life expectancy of patients with advanced schistosomiasis in Hunan Province, China.Infectious diseases of poverty · 2023Article
- The Efficiency of Commercial Immunodiagnostic Assays for the Field Detection ofPathogens (Basel, Switzerland) · 2022Article
- GPS-based fine-scale mapping surveys for schistosomiasis assessment: a practical introduction and documentation of field implementation.Infectious diseases of poverty · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
Abstract
purposeFor the evolution of schistosomiasis in China, a systematic review was provided about the history of the disease and its public health impacts. We aimed to depict the journey from disease discovery to elimination and the experience and lessons learned during the process.
methodsWe systematically reviewed the Chinese history of schistosomiasis and its public health impacts and collected data on the disease by searching relevant books and articles.
resultsAn important milestone for the disease discovery is that Schistosoma japonicum eggs were identified in the two Chinese corpses dating back to around 2180 years ago. The earliest Chinese ancient book documented symptoms resembling schistosomiasis that could date back to about 4700 years ago. The first nationwide survey on the disease in the mid-1950s revealed that schistosomiasis was endemic in 433 counties or cities of 12 provinces and affected about 11.6 million people in China. The Chinese government has provided continuous investment in schistosoiasis control, and the national multifaceted, integrated control programs have been uninterruptedly implemented since 1955. Schistosomiasis control in China can be divided into six stages, and various schistosomiasis control strategies have been developed and adjusted. The number of schistosomiasis cases decreased from 11.6 million in 1950s to 38,000 in 2017 and the number of acute cases decreased from 13,191 in 1989 to only 1 in 2017.
conclusionsSchistosomiasis transmission has been under control in all parts of China since 2017. An elimination of schistosomiasis can be achieved in the foreseeable future in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.